SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-015171
Filing Date
2024-04-08
Accepted
2024-04-08 13:13:16
Documents
14
Period of Report
2024-04-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ocgn-20240408.htm   iXBRL 8-K 29081
2 EX-99.1 ocgn-20240408xex991.htm EX-99.1 14279
  Complete submission text file 0001628280-24-015171.txt   171429

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20240408.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20240408_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20240408_pre.xml EX-101.PRE 12506
17 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20240408_htm.xml XML 2712
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 24828943
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)